Insider · CIK 0001670431

Martins Eduardo Bruno

Reports to the SEC for 2 companies · SAN MATEO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001670431

Forms 4 and 5

Insider transactions

15 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-02-19	SGMTSagimet Biosciences Inc.A Award	Chief Medical Officer	AAward	+44K sh	—	—	147,296
2026-02-19	SGMTSagimet Biosciences Inc. · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+88K sh	—	—	88,000
2026-02-10	SGMTSagimet Biosciences Inc.S Sale	Chief Medical Officer	SSale	−3,640 sh	$5.36	−$19.5K	103,296
2025-07-21	SGMTSagimet Biosciences Inc.S Sale	Chief Medical Officer	SSale	−8,277 sh	$9.13	−$75.6K	106,936
2025-02-06	SGMTSagimet Biosciences Inc.A Award	Chief Medical Officer	AAward	+34K sh	—	—	115,213
2025-02-06	SGMTSagimet Biosciences Inc. · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+138K sh	—	—	138,000
2024-07-19	SGMTSagimet Biosciences Inc.S Sale	Chief Medical Officer	SSale	−8,357 sh	$3.10	−$25.9K	81,213
2023-11-17	SGMTSagimet Biosciences Inc.A Award	Chief Medical Officer	AAward	+89.6K sh	—	—	89,570
2023-07-18	SGMTSagimet Biosciences Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−198K sh	—	—	0
2023-07-18	SGMTSagimet Biosciences Inc. · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+198K sh	—	—	198,132
2023-07-18	SGMTSagimet Biosciences Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−44K sh	—	—	0
2023-07-18	SGMTSagimet Biosciences Inc. · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+44K sh	—	—	44,009
2017-03-09	Eiger BioPharmaceuticals, Inc.Stock Option (Right to Buy)A Award	SVP, Liver and Infectious Dise	AAward	+30K sh	—	—	30,000
2016-03-23	Eiger BioPharmaceuticals, Inc.Stock Option (Right to Buy)A Award	SVP, Liver and Infectious Dise	AAward	+65.2K sh	—	—	65,216
2016-03-23	Eiger BioPharmaceuticals, Inc.Stock Option (Right to Buy)A Award	SVP, Liver and Infectious Dise	AAward	+65.2K sh	—	—	65,216

Recent filings

Accepted (ET)
Feb 204
Martins Eduardo Bruno0001104659-26-018194
SEC(opens sec.gov)
Feb 124
Martins Eduardo Bruno0001104659-26-014272
SEC(opens sec.gov)
Jul 234
Martins Eduardo Bruno0001104659-25-070015
SEC(opens sec.gov)
Feb 74
Martins Eduardo Bruno0001104659-25-010589
SEC(opens sec.gov)
Jul 234
Martins Eduardo Bruno0001104659-24-081892
SEC(opens sec.gov)
Nov 214
Martins Eduardo Bruno0001104659-23-120375
SEC(opens sec.gov)
Jul 204
Martins Eduardo Bruno0001104659-23-082727
SEC(opens sec.gov)
Mar 144
Eiger BioPharmaceuticals, Inc.0001209191-17-020648
SEC(opens sec.gov)
Sep 154/A
Eiger BioPharmaceuticals, Inc.0001209191-16-141546
SEC(opens sec.gov)
Mar 284
Eiger BioPharmaceuticals, Inc.0001209191-16-110839
SEC(opens sec.gov)

Companies

Address

SAGIMET BIOSCIENCES INC. 155 BOVET ROAD, SUITE 303

SAN MATEO, CA, 94402